Arkansas Psychiatric Society Annual Conference
The APA designates this live activity for a maximum of 6 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
April 6, 2019
The Jackson T. Stephens Spine and Neurosciences Institute, 12th floor, UAMS
Arkansas Psychiatric Society 2019 Conference
“Opioids & Cannabinoids: Novel Therapies or Just Another Buzz?”
Saturday, April 6, 2019
8:00 am – 4:00 pm
APS Executive Council Meeting 4:10 pm – 5:00 pm
UAMS Jackson T. Stephens Spine & Neurosciences Institute
8:00 AM – 8:30 AM: Breakfast/Networking
8:30 AM- 8:45 AM: Introduction & Welcome
Raymond Molden, MD, President, Arkansas Psychiatric Society
8:45 AM – 9:45 AM: “Medical Marijuana in Arkansas: The Law and Treatment Considerations”
Ronald G. Thompson, Jr., PhD., LCSW
9:45 AM – 10:45 AM: “Evaluating the Therapeutic Potential of Cannabinoids”
David Shurtleff, PhD., Deputy Director National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH), Bethesda, MD.
10:45 AM – 10:55 AM: Break
11:00 AM – 12:00 PM: “Understanding Cannabis and Its Use in Modern Medicine”
Ryan Vandrey, MD, Associate Professor, Johns Hopkins University School of Medicine
12:00 PM - 1:00 PM: Lunch
1:00 PM – 2:00 PM: “Can We Talk-The Difficult Encounter ”
Jonathan Goree, MD, Director of Chronic Pain Division, Assistant Professor in Department of Anesthesiology
2:00 PM – 3:00 PM: “Perinatal Opioid Use Disorder ”
Shona Ray-Griffith, MD, Assistant Professor, UAMS Department of Psychiatry
3:00 PM – 4:00 PM: “Medication Assisted Treatment for Opioid Use Disorder: An Update”
Michael Mancino, MD, Associate Professor, UAMS Department of Psychiatry
4:10 PM – 5:00 PM: Arkansas Executive Council Meeting
Adjourn